Diacerein can modulate the Sphk1/S1P axis, reduce the levels of GSK-3β, STAT3, and Caspase-3, while increasing the expression of BCL-2 protein, thereby contributing to the treatment of acute lung injury. Here, SPHK1 is linked to injury.